Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 2 | EP6955 | — |
sore arm; inappropriate schedule of vaccine administered; This is a spontaneous report received from a Consumer or other non HCP. A 77-year-old patient received BNT162b2 (BNT162B2), on 27Mar2021 as dose 2, single (Lot number: EP6955) for covid-19 immunisation. The patient's relevant medical history included: "thyroid" (unspecified if ongoing); "cataracts are forming over the last few years" (ongoing); "Penicillin allergy" (unspecified if ongoing); "sulfa allergy" (unspecified if ongoing); "tetracycline allergy" (unspecified if ongoing); "latex allergy" (unspecified if ongoing); "allergies" (unspecified if ongoing); "deaf/profound hearing loss" (ongoing), notes: 50+ years; "Wore oticon 380P hearing aids" (ongoing). Concomitant medication(s) included: LEVOXYL taken for thyroid disorder; CLARITIN [CLARITHROMYCIN]. Vaccination history included: Biontech (dose 1; lot: FL3198), administration date: Apr2020, for covid-19 immunization, reaction(s): "sore arm". The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset 27Mar2021, outcome "unknown", described as "inappropriate schedule of vaccine administered"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm". No follow-up attempts are possible.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202500021060 same patient/product/event; different dose;
Cataracts; Hearing aid user; Hearing loss (50+ years)
Medical History/Concurrent Conditions: Allergic reaction to antibiotics; Latex allergy; Multiple allergies; Penicillin allergy; Sulfonamide allergy; Thyroid disorder
LEVOXYL; CLARITIN [CLARITHROMYCIN]